Brought to you by 
Aspect Medical nets $105.6mm in convertible debt financing
10 Jul 2007
Executive Summary
Brain monitoring device maker Aspect Medical Systems has netted $105.6mm by selling 2.5% seven-year senior notes to institutional investors under Rule 144A. The notes convert into stock at a rate of 52.4294 shares per $1k notes, or $19.07 per share. (The shares averaged $16.01 at announcement.) Backers also received an option to purchase another $15mm in notes. Aspect plans to use the money to buy back some of its shares sold to Boston Scientific through a 2002 deal that was recently terminated.
Deal Industry
- Medical Devices
-
Medical Devices
- Monitoring Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- Convertible Debt
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aspect Medical nets $105.6mm in convertible debt financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice